At present, the most common fluorescence probe targets for PD biomarkers include α-Syn, type B monoamine oxidase (MAO-B), dopamine-associated proteins (DATs and DARs), metal ions, ROS clusters, etc. However, these targets are just subjected to researches in vitro and at the animal level, without clinical applications. The gene discussed is MAOB; the disease is Parkinson disease.